Bioactive alkenylphenols from Piper obliquum

Area of Science:

• Phytochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Piper obliquum is traditionally used for its medicinal properties.
• Natural products are a rich source of novel therapeutic agents.
• Understanding the chemical constituents and bioactivity of medicinal plants is crucial.

Purpose of the Study:

• To isolate and identify new chemical compounds from Piper obliquum.
• To synthesize obliquol B for structural confirmation and biological evaluation.
• To investigate the antibacterial and anti-inflammatory potential of isolated compounds.

Main Methods:

• Phytochemical investigation involving extraction and isolation of compounds from Piper obliquum.
• Structure elucidation of new compounds using spectroscopic methods.
• Chemical synthesis of obliquol B.
• In vitro assays to determine antibacterial activity and inhibition of the NF-kappaB pathway.

Main Results:

• Two new alkenylphenols, obliquol A (1) and obliquol B (2), and a new 4-chromanone (3) were isolated, along with known compounds (4, 5).
• Obliquol A and B demonstrated antibacterial activity comparable to ampicillin.
• Obliquol B exhibited potent inhibition of the tumor necrosis factor alpha (TNFalpha)-induced nuclear factor kappa B (NF-kappaB) inflammatory pathway.

Conclusions:

• Piper obliquum is a source of novel bioactive compounds with potential therapeutic applications.
• Obliquol B's anti-NF-kappaB activity provides a molecular basis for the traditional use of Piper obliquum in inflammatory conditions.
• Further research into obliquol B could lead to the development of new anti-inflammatory agents.